Jason R. Kelly, See remarks at Ginkgo Bioworks Holdings, Inc. (DNA), sold 200,000 shares at $1.35 ($280K) on 2023-11-30, disclosed to the SEC on 2023-12-01.
Scheduled sale ($280k) by See remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.45 | 100,000 | $145K | 51.8% |
| 2 | $1.35 | 100,000 | $135K | 48.2% |
| Total | $1.40 avg | 200,000 | $280K | 100% |
| Filing → |
| DNA | SELL | 2023-12-22 | $353K | — | Filing → |
| DNA | SELL | 2023-12-15 | $595K | — | Filing → |
| DNA | SELL | 2023-12-08 | $263K | — | Filing → |